Fineline Cube

Follow:
14389 Articles
R&D

China Launches Unprecedented Multi-Center Hypertension Study with Global Implications

Company

China Biopharma Posts 216% Revenue Increase, Eyes US$10 Million in 2007 with Vaccine Distribution and New Treatments

Policy / Regulatory

Shanghai to Launch China’s Largest ADR Database, Enhancing Pharmaceutical Oversight

Policy / Regulatory

China Unveils TCM Development Guidelines: A Strategic Defense of Traditional Medicine

Company

India Launches Anti-Dumping Campaign Against Chinese Vitamin B12 and Ceftriaxone Sodium Producers

Company

Novartis Sees 15% Global Sales Growth and Significant Investment in China for 2006

HospitalR&D

Ruijin Hospital Researchers Uncover Five New Mutations in Rare 17OHD Endocrine Disorder

Policy / Regulatory

China’s SFDA Mandates Official Position Rotation to Boost Transparency

Policy / Regulatory

Guangdong’s ‘Sunlight Purchase’ System Sparks Drug Pricing War and Uncovers Pricing Anomalies

HospitalR&D

Ruijin Hospital Unveils Five New Mutations in Rare Adrenal Hyperplasia Study

Policy / Regulatory

SFDA Embraces Transparency: Regular Press Briefings and Personnel Rotations Announced

Company

China’s Western Pharmaceutical Exports Soar 23% in 2006, Led by Antibiotics